Related Experiment Video
Updated: May 17, 2026
06:38
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
Published on: February 28, 2025
Flavaglines as potent anticancer and cytoprotective agents
Nigel Ribeiro1, Frédéric Thuaud, Yohann Bernard
1Therapeutic Innovation Laboratory, UMR7200, CNRS/Université de Strasbourg, Illkirch, France.
Journal of Medicinal Chemistry
|October 18, 2012
Summary
Novel flavagline derivatives show promise as anticancer agents and offer protection against heart and nerve damage. These compounds may also prevent chemotherapy-induced neurotoxicity, a significant clinical finding.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Flavaglines are plant-derived compounds with known anticancer, cardioprotective, and neuroprotective properties.
- Understanding the structure-activity relationships of flavaglines is crucial for developing new therapeutic agents.
- Cisplatin chemotherapy can cause severe neurotoxicity, limiting its clinical use.
Purpose of the Study:
- To synthesize novel flavagline derivatives.
- To evaluate their efficacy in anticancer, cardioprotective, and neuroprotective assays.
- To elucidate the structural requirements for these activities and explore their potential against cisplatin-induced neurotoxicity.
Main Methods:
- Synthesis of novel flavagline derivatives.
- Cytotoxicity assays on human cancer cell lines.
- Cardioprotection assays using doxorubicin-induced apoptosis in cardiomyocytes.
- Neuroprotection assays in Parkinson's disease and cisplatin neurotoxicity models.
Main Results:
- Novel flavagline derivatives were synthesized and tested.
- The structural requirements for cardioprotection and neuroprotection were distinct from those for cytotoxicity.
- Flavaglines demonstrated potential in alleviating cisplatin-induced neurotoxicity.
Conclusions:
- Flavagline derivatives possess diverse therapeutic potential, including anticancer, cardioprotective, and neuroprotective effects.
- The study unraveled unique structural requirements for flavagline's protective activities.
- Flavaglines show promise for preventing chemotherapy-induced neurotoxicity, offering a potential prophylactic strategy.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...